KIM LLC’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

KIM LLC’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-92,040	Closed	-$9.11K	–	163
2024 Q2	$9.11K	Hold	92,040	–	–	﹤0.01%	154
2024 Q1	$14.7K	Hold	92,040	–	–	﹤0.01%	146
2023 Q4	$6.51K	Buy	+92,040	New	+$12.4K	﹤0.01%	251
2023 Q3	–	Sell	-92,040	Closed	-$21K	–	423
2023 Q2	$21K	Hold	92,040	–	–	﹤0.01%	264
2023 Q1	$12.9K	Hold	92,040	–	–	﹤0.01%	367
2022 Q4	$8K	Hold	92,040	–	–	﹤0.01%	480
2022 Q3	$13K	Hold	92,040	–	–	﹤0.01%	609
2022 Q2	$24K	Buy	+92,040	New	+$36.4K	﹤0.01%	588

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

KIM LLC's NKGNW Position: Q3 2024 in Review

KIM LLC sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2024, closing a stake of 92,040 shares — an estimated $9.11K sold.

KIM LLC first reported a position in NKGNW in Q2 2022 and held it in 8 quarters. The position peaked at $24K in Q2 2022. 29 funds tracked by Wall St. Rank hold NKGNW as of Q3 2024.

KIM LLC reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2024 after selling out during the quarter.
KIM LLC sold 92,040 NKGen Biotech, Inc. Warrants shares in Q3 2024, an estimated $9.11K.
KIM LLC first reported a position in NKGen Biotech, Inc. Warrants in Q2 2022 and held it in 8 quarters.
KIM LLC's NKGen Biotech, Inc. Warrants position peaked at $24K in Q2 2022.
29 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2024.

Based on KIM LLC's 13F filing for Q3 2024, filed 13 Nov 2024.